David Larsen
Stock Analyst at BTIG
(0.19)
# 4,419
Out of 4,574 analysts
577
Total ratings
34.9%
Success rate
-4.5%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Maintained: Buy | $17 → $25 | $15.37 | +62.65% | 31 | Jul 24, 2026 | |
| HQY HealthEquity | Maintained: Buy | $110 → $115 | $94.64 | +21.52% | 31 | Jul 24, 2026 | |
| PGNY Progyny | Maintained: Buy | $30 → $40 | $31.19 | +28.25% | 19 | Jul 24, 2026 | |
| LFST LifeStance Health Group | Maintained: Buy | $12 → $15 | $10.90 | +37.61% | 6 | Jul 24, 2026 | |
| CCSI Consensus Cloud Solutions | Maintained: Buy | $40 → $45 | $36.37 | +23.73% | 12 | Jul 24, 2026 | |
| OMDA Omada Health | Initiated Coverage: Buy | $30 | $20.53 | +46.13% | 1 | Jul 17, 2026 | |
| EVH Evolent Health | Rated: Buy | $8 | $4.22 | +89.57% | 51 | Jul 16, 2026 | |
| ASTH Astrana Health | Rated: Buy | $50 → $65 | $40.31 | +61.25% | 15 | Jul 16, 2026 | |
| TOI The Oncology Institute | Maintained: Buy | $9 | $4.98 | +80.72% | 12 | Jul 15, 2026 | |
| BTSG BrightSpring Health Services | Rated: Buy | $90 | $72.91 | +23.44% | 18 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $19 | $18.34 | +0.87% | 18 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $100 | $85.47 | +17.00% | 14 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $38.75 | +41.94% | 5 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $340 | $186.24 | +82.56% | 13 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $20.42 | - | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.08 | - | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.5958 | - | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.683 | - | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.71 | +169.54% | 43 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.81 | - | 25 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.77 | - | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $41.00 | - | 25 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $28.09 | - | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $208.05 | - | 11 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.62 | - | 10 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $98.00 | - | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $25.50 | n/a | 15 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 16 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $309.89 | n/a | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $226.58 | n/a | 2 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $107.74 | n/a | 28 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $65 → $55 | $228.03 | n/a | 12 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $9 | $3.14 | n/a | 6 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $160 | $840.90 | n/a | 11 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $13 | $5.14 | n/a | 8 | Jun 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | - | n/a | 3 | Nov 3, 2016 |
Cryoport
Jul 24, 2026
Maintained: Buy
Price Target: $17 → $25
Current: $15.37
Upside: +62.65%
HealthEquity
Jul 24, 2026
Maintained: Buy
Price Target: $110 → $115
Current: $94.64
Upside: +21.52%
Progyny
Jul 24, 2026
Maintained: Buy
Price Target: $30 → $40
Current: $31.19
Upside: +28.25%
LifeStance Health Group
Jul 24, 2026
Maintained: Buy
Price Target: $12 → $15
Current: $10.90
Upside: +37.61%
Consensus Cloud Solutions
Jul 24, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $36.37
Upside: +23.73%
Omada Health
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $20.53
Upside: +46.13%
Evolent Health
Jul 16, 2026
Rated: Buy
Price Target: $8
Current: $4.22
Upside: +89.57%
Astrana Health
Jul 16, 2026
Rated: Buy
Price Target: $50 → $65
Current: $40.31
Upside: +61.25%
The Oncology Institute
Jul 15, 2026
Maintained: Buy
Price Target: $9
Current: $4.98
Upside: +80.72%
BrightSpring Health Services
Jul 6, 2026
Rated: Buy
Price Target: $90
Current: $72.91
Upside: +23.44%
Jun 16, 2026
Rated: Hold
Price Target: $19
Current: $18.34
Upside: +0.87%
Jun 11, 2026
Upgraded: Buy
Price Target: $100
Current: $85.47
Upside: +17.00%
Jun 9, 2026
Reiterated: Buy
Price Target: $55
Current: $38.75
Upside: +41.94%
Jun 3, 2026
Rated: Buy
Price Target: $340
Current: $186.24
Upside: +82.56%
May 14, 2026
Downgraded: Hold
Price Target: n/a
Current: $20.42
Upside: -
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $2.08
Upside: -
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $0.5958
Upside: -
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $0.683
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $10
Current: $3.71
Upside: +169.54%
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $10.81
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $8.77
Upside: -
Apr 28, 2026
Maintained: Hold
Price Target: n/a
Current: $41.00
Upside: -
Mar 5, 2026
Maintained: Hold
Price Target: n/a
Current: $28.09
Upside: -
Feb 5, 2026
Maintained: Hold
Price Target: n/a
Current: $208.05
Upside: -
Nov 14, 2025
Rated: Hold
Price Target: n/a
Current: $9.62
Upside: -
Nov 4, 2025
Rated: Hold
Price Target: n/a
Current: $98.00
Upside: -
Mar 5, 2025
Maintained: Buy
Price Target: $35
Current: $25.50
Upside: n/a
Jun 23, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $309.89
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $226.58
Upside: n/a
Aug 14, 2019
Rated: Hold
Price Target: n/a
Current: $107.74
Upside: n/a
Nov 16, 2018
Downgraded: Hold
Price Target: $65 → $55
Current: $228.03
Upside: n/a
Oct 31, 2018
Maintained: Hold
Price Target: $17 → $9
Current: $3.14
Upside: n/a
May 29, 2018
Reiterated: Hold
Price Target: $170 → $160
Current: $840.90
Upside: n/a
Jun 19, 2017
Downgraded: Hold
Price Target: $17 → $13
Current: $5.14
Upside: n/a
Nov 3, 2016
Reiterated: Hold
Price Target: $9
Current: -
Upside: n/a